In vitro activity of timentin against community and hospital-acquired gram-negative bacterial isolates.
Glupczynski
Y
Y
McGillavry
G
G
Yourassowsky
E
E
D001424:Bacterial Infections / Q000188:drug therapy*; D002969:Clavulanic Acids / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006090:Gram-Negative Bacteria; D006801:Humans; D010406:Penicillins / Q000627:therapeutic use*; D013982:Ticarcillin / Q000627:therapeutic use*; D065093:beta-Lactamase Inhibitors
D002969:Clavulanic Acids; D010406:Penicillins; D065093:beta-Lactamase Inhibitors; C043215:ticarcillin-clavulanic acid; D013982:Ticarcillin